Derek Hicks

Insider Reports History

Entity
Individual
Location
C/O Intellia Therapeutics, Inc., 40 Erie Street Suite 130, Cambridge, MA
Signature
James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Derek Hicks:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. EVP, Chief Business Officer Common Stock 66.4K $2.19M $32.99 Mar 1, 2024 Direct
Intellia Therapeutics, Inc. EVP, Chief Business Officer Stock Option (right to buy) 42.4K Mar 1, 2024 Direct

Insider Reports Filed by Derek Hicks

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NTLA Intellia Therapeutics, Inc. Mar 1, 2024 2 $0 4 Mar 5, 2024 EVP, Chief Business Officer
NTLA Intellia Therapeutics, Inc. Jan 3, 2024 1 -$114K 4 Jan 5, 2024 EVP, Chief Business Officer
NTLA Intellia Therapeutics, Inc. Mar 1, 2023 2 $0 4 Mar 3, 2023 EVP, Chief Business Officer
NTLA Intellia Therapeutics, Inc. Jan 4, 2023 1 -$67.4K 4 Jan 6, 2023 EVP, Chief Business Officer
NTLA Intellia Therapeutics, Inc. Jan 3, 2022 2 $0 4 Jan 5, 2022 EVP, Chief Business Officer
NTLA Intellia Therapeutics, Inc. Dec 20, 2021 0 $0 3 Dec 29, 2021 EVP, Chief Business Officer